Eyebright Medical Technology Beijing Co Ltd
SSE:688050
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | EV/FCFF | ||||
---|---|---|---|---|---|
CN |
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
8B CNY | -98.3 | ||
CH |
Alcon AG
SIX:ALC
|
40.3B CHF | 62.7 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 36.6 | ||
DK |
Coloplast A/S
CSE:COLO B
|
187.4B DKK | 196.3 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19B USD | 29.8 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 175.4 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58B CNY | 48.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 528.2 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.4B CHF | -172.8 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.6B USD | 25.5 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.7T KRW | -59.6 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.